138 related articles for article (PubMed ID: 11198929)
1. Variations in mRNA content have no effect on the potency of antisense oligonucleotides.
Miraglia L; Watt AT; Graham MJ; Crooke ST
Antisense Nucleic Acid Drug Dev; 2000 Dec; 10(6):453-61. PubMed ID: 11198929
[TBL] [Abstract][Full Text] [Related]
2. Antisense oligonucleotides inhibit intercellular adhesion molecule 1 expression by two distinct mechanisms.
Chiang MY; Chan H; Zounes MA; Freier SM; Lima WF; Bennett CF
J Biol Chem; 1991 Sep; 266(27):18162-71. PubMed ID: 1680858
[TBL] [Abstract][Full Text] [Related]
3. Selective inhibition of mutant Ha-ras mRNA expression by antisense oligonucleotides.
Monia BP; Johnston JF; Ecker DJ; Zounes MA; Lima WF; Freier SM
J Biol Chem; 1992 Oct; 267(28):19954-62. PubMed ID: 1400312
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of endothelial cell adhesion molecule expression with antisense oligonucleotides.
Bennett CF; Condon TP; Grimm S; Chan H; Chiang MY
J Immunol; 1994 Apr; 152(7):3530-40. PubMed ID: 7511650
[TBL] [Abstract][Full Text] [Related]
5. 2'-O-[2-[(N,N-dimethylamino)oxy]ethyl]-modified oligonucleotides inhibit expression of mRNA in vitro and in vivo.
Prakash TP; Johnston JF; Graham MJ; Condon TP; Manoharan M
Nucleic Acids Res; 2004; 32(2):828-33. PubMed ID: 14762210
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of 2'-modified oligonucleotides containing 2'-deoxy gaps as antisense inhibitors of gene expression.
Monia BP; Lesnik EA; Gonzalez C; Lima WF; McGee D; Guinosso CJ; Kawasaki AM; Cook PD; Freier SM
J Biol Chem; 1993 Jul; 268(19):14514-22. PubMed ID: 8390996
[TBL] [Abstract][Full Text] [Related]
7. On the in vitro and in vivo properties of four locked nucleic acid nucleotides incorporated into an anti-H-Ras antisense oligonucleotide.
Fluiter K; Frieden M; Vreijling J; Rosenbohm C; De Wissel MB; Christensen SM; Koch T; Ørum H; Baas F
Chembiochem; 2005 Jun; 6(6):1104-9. PubMed ID: 15861430
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of protein kinase C-alpha expression in human A549 cells by antisense oligonucleotides inhibits induction of intercellular adhesion molecule 1 (ICAM-1) mRNA by phorbol esters.
Dean NM; McKay R; Condon TP; Bennett CF
J Biol Chem; 1994 Jun; 269(23):16416-24. PubMed ID: 7911467
[TBL] [Abstract][Full Text] [Related]
9. Efficient reduction of target RNAs by small interfering RNA and RNase H-dependent antisense agents. A comparative analysis.
Vickers TA; Koo S; Bennett CF; Crooke ST; Dean NM; Baker BF
J Biol Chem; 2003 Feb; 278(9):7108-18. PubMed ID: 12500975
[TBL] [Abstract][Full Text] [Related]
10. Effects of antisense oligonucleotide-mediated depletion of tumor necrosis factor (TNF) receptor 1-associated death domain protein on TNF-induced gene expression.
Siwkowski AM; Madge LA; Koo S; McMillan EL; Monia BP; Pober JS; Baker BF
Mol Pharmacol; 2004 Sep; 66(3):572-9. PubMed ID: 15322249
[TBL] [Abstract][Full Text] [Related]
11. Increased efficacy of antileishmanial antisense phosphorothioate oligonucleotides in Leishmania amazonensis overexpressing ribonuclease H.
Mishra M; Bennett JR; Chaudhuri G
Biochem Pharmacol; 2001 Feb; 61(4):467-76. PubMed ID: 11226381
[TBL] [Abstract][Full Text] [Related]
12. Rational selection and quantitative evaluation of antisense oligonucleotides.
Jayaraman A; Walton SP; Yarmush ML; Roth CM
Biochim Biophys Acta; 2001 Aug; 1520(2):105-14. PubMed ID: 11513951
[TBL] [Abstract][Full Text] [Related]
13. Effects of oligonucleotide length, mismatches and mRNA levels on C-5 propyne-modified antisense potency.
Flanagan WM; Kothavale A; Wagner RW
Nucleic Acids Res; 1996 Aug; 24(15):2936-41. PubMed ID: 8760877
[TBL] [Abstract][Full Text] [Related]
14. Enhanced metastatic ability of TNF-alpha-treated malignant melanoma cells is reduced by intercellular adhesion molecule-1 (ICAM-1, CD54) antisense oligonucleotides.
Miele ME; Bennett CF; Miller BE; Welch DR
Exp Cell Res; 1994 Sep; 214(1):231-41. PubMed ID: 7915992
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of C-5 propynyl pyrimidine-containing oligonucleotides in vitro and in vivo.
Shen L; Siwkowski A; Wancewicz EV; Lesnik E; Butler M; Witchell D; Vasquez G; Ross B; Acevedo O; Inamati G; Sasmor H; Manoharan M; Monia BP
Antisense Nucleic Acid Drug Dev; 2003; 13(3):129-42. PubMed ID: 12954113
[TBL] [Abstract][Full Text] [Related]
16. Cationic lipid is not required for uptake and selective inhibitory activity of ICAM-1 phosphorothioate antisense oligonucleotides in keratinocytes.
Nestle FO; Mitra RS; Bennett CF; Chan H; Nickoloff BJ
J Invest Dermatol; 1994 Oct; 103(4):569-75. PubMed ID: 7930684
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of ICAM-1 gene expression by antisense 2',4'-BNA oligonucleotides.
Obika S; Hemamayi R; Masuda T; Sugimoto T; Nakagawa S; Mayumi T; Imanishi T
Nucleic Acids Res Suppl; 2001; (1):145-6. PubMed ID: 12836306
[TBL] [Abstract][Full Text] [Related]
18. Elucidation of gene function using C-5 propyne antisense oligonucleotides.
Flanagan WM; Su LL; Wagner RW
Nat Biotechnol; 1996 Sep; 14(9):1139-45. PubMed ID: 9631067
[TBL] [Abstract][Full Text] [Related]
19. Intercellular adhesion molecule-1 suppression in skin by topical delivery of anti-sense oligonucleotides.
Mehta RC; Stecker KK; Cooper SR; Templin MV; Tsai YJ; Condon TP; Bennett CF; Hardee GE
J Invest Dermatol; 2000 Nov; 115(5):805-12. PubMed ID: 11069617
[TBL] [Abstract][Full Text] [Related]
20. Efficient and isoform-selective inhibition of cellular gene expression by peptide nucleic acids.
Liu Y; Braasch DA; Nulf CJ; Corey DR
Biochemistry; 2004 Feb; 43(7):1921-7. PubMed ID: 14967032
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
